ArticleOphthalmology2013

Diagnosis of occult melanoma using transient receptor potential melastatin 1 (TRPM1) autoantibody testing: a novel approach.

Monica D Dalal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.